2
|
Meller T, Schmitt S, Stein F, Brosch K, Mosebach J, Yüksel D, Zaremba D, Grotegerd D, Dohm K, Meinert S, Förster K, Redlich R, Opel N, Repple J, Hahn T, Jansen A, Andlauer TFM, Forstner AJ, Heilmann-Heimbach S, Streit F, Witt SH, Rietschel M, Müller-Myhsok B, Nöthen MM, Dannlowski U, Krug A, Kircher T, Nenadić I. Associations of schizophrenia risk genes ZNF804A and CACNA1C with schizotypy and modulation of attention in healthy subjects. Schizophr Res 2019; 208:67-75. [PMID: 31076262 DOI: 10.1016/j.schres.2019.04.018] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/24/2018] [Revised: 03/05/2019] [Accepted: 04/20/2019] [Indexed: 12/30/2022]
Abstract
Schizotypy is a multidimensional risk phenotype distributed in the general population, constituting of subclinical, psychotic-like symptoms. It is associated with psychosis proneness, and several risk genes for psychosis are associated with schizotypy in non-clinical populations. Schizotypy might also modulate cognitive abilities as it is associated with attentional deficits in healthy subjects. In this study, we tested the hypothesis that established genetic risk variants ZNF804A rs1344706 and CACNA1C rs1006737 are associated with psychometric schizotypy and that schizotypy mediates their effect on attention or vice versa. In 615 healthy subjects from the FOR2107 cohort study, we analysed the genetic risk variants ZNF804A rs1344706 and CACNA1C rs1006737, psychometric schizotypy (schizotypal personality questionnaire-brief SPQB), and a neuropsychological measure of sustained and selective attention (d2 test). ZNF804A rs1344706 C (non-risk) alleles were significantly associated with higher SPQ-B Cognitive-Perceptual subscores in women and with attention deficits in both sexes. This schizotypy dimension also mediated the effect of ZNF804A on attention in women, but not in men. CACNA1C rs1006737-A showed a significant sex-modulated negative association with Interpersonal schizotypy only in men, and no effect on attention. Our multivariate model demonstrates differential genetic contributions of two psychosis risk genes to dimensions of schizotypy and, partly, to attention. This supports a model of shared genetic influence between schizotypy and cognitive functions impaired in schizophrenia.
Collapse
Affiliation(s)
- Tina Meller
- Department of Psychiatry and Psychotherapy, Philipps-Universität Marburg and University Hospital Marburg, UKGM, Rudolf-Bultmann-Str. 8, 35039 Marburg, Germany; Center for Mind, Brain and Behavior (CMBB), Hans-Meerwein-Str. 6, 35032 Marburg, Germany.
| | - Simon Schmitt
- Department of Psychiatry and Psychotherapy, Philipps-Universität Marburg and University Hospital Marburg, UKGM, Rudolf-Bultmann-Str. 8, 35039 Marburg, Germany; Center for Mind, Brain and Behavior (CMBB), Hans-Meerwein-Str. 6, 35032 Marburg, Germany
| | - Frederike Stein
- Department of Psychiatry and Psychotherapy, Philipps-Universität Marburg and University Hospital Marburg, UKGM, Rudolf-Bultmann-Str. 8, 35039 Marburg, Germany; Center for Mind, Brain and Behavior (CMBB), Hans-Meerwein-Str. 6, 35032 Marburg, Germany
| | - Katharina Brosch
- Department of Psychiatry and Psychotherapy, Philipps-Universität Marburg and University Hospital Marburg, UKGM, Rudolf-Bultmann-Str. 8, 35039 Marburg, Germany; Center for Mind, Brain and Behavior (CMBB), Hans-Meerwein-Str. 6, 35032 Marburg, Germany
| | - Johannes Mosebach
- Department of Psychiatry and Psychotherapy, Philipps-Universität Marburg and University Hospital Marburg, UKGM, Rudolf-Bultmann-Str. 8, 35039 Marburg, Germany
| | - Dilara Yüksel
- Department of Psychiatry and Psychotherapy, Philipps-Universität Marburg and University Hospital Marburg, UKGM, Rudolf-Bultmann-Str. 8, 35039 Marburg, Germany; SRI International, Center for Health Sciences, Bioscience Division, 333 Ravenswood Avenue, 94025 Menlo Park, CA, USA
| | - Dario Zaremba
- Department of Psychiatry and Psychotherapy, Westfälische Wilhelms-Universität Münster, Albert-Schweitzer-Campus 1, Building A9, 48149 Münster, Germany
| | - Dominik Grotegerd
- Department of Psychiatry and Psychotherapy, Westfälische Wilhelms-Universität Münster, Albert-Schweitzer-Campus 1, Building A9, 48149 Münster, Germany
| | - Katharina Dohm
- Department of Psychiatry and Psychotherapy, Westfälische Wilhelms-Universität Münster, Albert-Schweitzer-Campus 1, Building A9, 48149 Münster, Germany
| | - Susanne Meinert
- Department of Psychiatry and Psychotherapy, Westfälische Wilhelms-Universität Münster, Albert-Schweitzer-Campus 1, Building A9, 48149 Münster, Germany
| | - Katharina Förster
- Department of Psychiatry and Psychotherapy, Westfälische Wilhelms-Universität Münster, Albert-Schweitzer-Campus 1, Building A9, 48149 Münster, Germany
| | - Ronny Redlich
- Department of Psychiatry and Psychotherapy, Westfälische Wilhelms-Universität Münster, Albert-Schweitzer-Campus 1, Building A9, 48149 Münster, Germany
| | - Nils Opel
- Department of Psychiatry and Psychotherapy, Westfälische Wilhelms-Universität Münster, Albert-Schweitzer-Campus 1, Building A9, 48149 Münster, Germany
| | - Jonathan Repple
- Department of Psychiatry and Psychotherapy, Westfälische Wilhelms-Universität Münster, Albert-Schweitzer-Campus 1, Building A9, 48149 Münster, Germany
| | - Tim Hahn
- Department of Psychiatry and Psychotherapy, Westfälische Wilhelms-Universität Münster, Albert-Schweitzer-Campus 1, Building A9, 48149 Münster, Germany
| | - Andreas Jansen
- Department of Psychiatry and Psychotherapy, Philipps-Universität Marburg and University Hospital Marburg, UKGM, Rudolf-Bultmann-Str. 8, 35039 Marburg, Germany; Center for Mind, Brain and Behavior (CMBB), Hans-Meerwein-Str. 6, 35032 Marburg, Germany; Core-Facility BrainImaging, Faculty of Medicine, Philipps-Universität Marburg, Rudolf-Bultmann-Str. 8, 35039 Marburg, Germany
| | - Till F M Andlauer
- Max-Planck-Institute of Psychiatry, Kraepelinstr. 2-10, 80804 Munich, Germany; Department of Neurology, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Straße 22, 81675 Munich, Germany
| | - Andreas J Forstner
- Institute of Human Genetics, University of Bonn School of Medicine & University Hospital Bonn, Sigmund-Freud-Straße 25, 53127 Bonn, Germany; Institute of Human Genetics, Philipps-Universität Marburg, Baldingerstraße, 35033 Marburg, Germany; Department of Biomedicine, University of Basel, Hebelstrasse 20, 4031 Basel, Switzerland; Institute of Medical Genetics and Pathology, University Hospital Basel, Schönbeinstr. 40, 4056 Basel, Switzerland
| | - Stefanie Heilmann-Heimbach
- Institute of Human Genetics, University of Bonn School of Medicine & University Hospital Bonn, Sigmund-Freud-Straße 25, 53127 Bonn, Germany
| | - Fabian Streit
- Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, J5, 68159 Mannheim, Germany
| | - Stephanie H Witt
- Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, J5, 68159 Mannheim, Germany
| | - Marcella Rietschel
- Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, J5, 68159 Mannheim, Germany
| | - Bertram Müller-Myhsok
- Max-Planck-Institute of Psychiatry, Kraepelinstr. 2-10, 80804 Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), Feodor-Lynen-Str. 17, 81377 Munich, Germany; Institute of Translational Medicine, University of Liverpool, Crown Street, Liverpool L69 3BX, UK
| | - Markus M Nöthen
- Institute of Human Genetics, University of Bonn School of Medicine & University Hospital Bonn, Sigmund-Freud-Straße 25, 53127 Bonn, Germany
| | - Udo Dannlowski
- Department of Psychiatry and Psychotherapy, Westfälische Wilhelms-Universität Münster, Albert-Schweitzer-Campus 1, Building A9, 48149 Münster, Germany
| | - Axel Krug
- Department of Psychiatry and Psychotherapy, Philipps-Universität Marburg and University Hospital Marburg, UKGM, Rudolf-Bultmann-Str. 8, 35039 Marburg, Germany; Center for Mind, Brain and Behavior (CMBB), Hans-Meerwein-Str. 6, 35032 Marburg, Germany
| | - Tilo Kircher
- Department of Psychiatry and Psychotherapy, Philipps-Universität Marburg and University Hospital Marburg, UKGM, Rudolf-Bultmann-Str. 8, 35039 Marburg, Germany; Center for Mind, Brain and Behavior (CMBB), Hans-Meerwein-Str. 6, 35032 Marburg, Germany
| | - Igor Nenadić
- Department of Psychiatry and Psychotherapy, Philipps-Universität Marburg and University Hospital Marburg, UKGM, Rudolf-Bultmann-Str. 8, 35039 Marburg, Germany; Center for Mind, Brain and Behavior (CMBB), Hans-Meerwein-Str. 6, 35032 Marburg, Germany
| |
Collapse
|
3
|
Steffens M, Meyhöfer I, Fassbender K, Ettinger U, Kambeitz J. Association of Schizotypy With Dimensions of Cognitive Control: A Meta-Analysis. Schizophr Bull 2018; 44:S512-S524. [PMID: 29554369 PMCID: PMC6188506 DOI: 10.1093/schbul/sby030] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Abstract
Schizotypy is defined as a time-stable multidimensional personality trait consisting of positive, negative, and disorganized facets. Schizotypy is considered as a model system of psychosis, as there is considerable overlap between the 2 constructs. High schizotypy is associated with subtle but fairly widespread cognitive alterations, which include poorer performance in tasks measuring cognitive control. Similar but more pronounced impairments in cognitive control have been described extensively in psychosis. We here sought to provide a quantitative estimation of the effect size of impairments in schizotypy in the updating, shifting, and inhibition dimensions of cognitive control. We included studies of healthy adults from both general population and college samples, which used either categorical or correlative designs. Negative schizotypy was associated with significantly poorer performance on shifting (g = 0.32) and updating (g = 0.11). Positive schizotypy was associated with significantly poorer performance on shifting (g = 0.18). There were no significant associations between schizotypy and inhibition. The divergence in results for positive, negative, and disorganized schizotypy emphasizes the importance of examining relationships between cognition and the facets of schizotypy rather than using the overall score. Our findings also underline the importance of more detailed research to further understand and define this complex personality construct, which will also be of importance when applying schizotypy as a model system for psychosis.
Collapse
Affiliation(s)
- Maria Steffens
- Department of Psychology, University of Bonn, Kaiser-Karl-Ring, Bonn, Germany
| | - Inga Meyhöfer
- Department of Psychology, University of Bonn, Kaiser-Karl-Ring, Bonn, Germany
| | - Kaja Fassbender
- Department of Psychology, University of Bonn, Kaiser-Karl-Ring, Bonn, Germany
| | - Ulrich Ettinger
- Department of Psychology, University of Bonn, Kaiser-Karl-Ring, Bonn, Germany,To whom correspondence should be addressed; tel: +49-228-734208, e-mail:
| | - Joseph Kambeitz
- Department of Psychiatry and Psychotherapy, University of Munich, Munich, Germany
| |
Collapse
|
4
|
Taurisano P, Romano R, Mancini M, Giorgio AD, Antonucci LA, Fazio L, Rampino A, Quarto T, Gelao B, Porcelli A, Papazacharias A, Ursini G, Caforio G, Masellis R, Niccoli-Asabella A, Todarello O, Popolizio T, Rubini G, Blasi G, Bertolino A. Prefronto-striatal physiology is associated with schizotypy and is modulated by a functional variant of DRD2. Front Behav Neurosci 2014; 8:235. [PMID: 25071490 PMCID: PMC4089730 DOI: 10.3389/fnbeh.2014.00235] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2014] [Accepted: 06/13/2014] [Indexed: 11/13/2022] Open
Abstract
“Schizotypy” is a latent organization of personality related to the genetic risk for schizophrenia. Some evidence suggests that schizophrenia and schizotypy share some biological features, including a link to dopaminergic D2 receptor signaling. A polymorphism in the D2 gene (DRD2 rs1076560, guanine > thymine (G > T)) has been associated with the D2 short/long isoform expression ratio, as well as striatal dopamine signaling and prefrontal cortical activity during different cognitive operations, which are measures that are altered in patients with schizophrenia. Our aim is to determine the association of schizotypy scores with the DRD2 rs1076560 genotype in healthy individuals and their interaction with prefrontal activity during attention and D2 striatal signaling. A total of 83 healthy subjects were genotyped for DRD2 rs1076560 and completed the Schizotypal Personality Questionnaire (SPQ). Twenty-six participants underwent SPECT with [123I]IBZM D2 receptor radiotracer, while 68 performed an attentional control task during fMRI. We found that rs1076560 GT subjects had greater SPQ scores than GG individuals. Moreover, the interaction between schizotypy and the GT genotype predicted prefrontal activity and related attentional behavior, as well as striatal binding of IBZM. No interaction was found in GG individuals. These results suggest that rs1076560 GT healthy individuals are prone to higher levels of schizotypy, and that the interaction between rs1076560 and schizotypy scores modulates phenotypes related to the pathophysiology of schizophrenia, such as prefrontal activity and striatal dopamine signaling. These results provide systems-level qualitative evidence for mapping the construct of schizotypy in healthy individuals onto the schizophrenia continuum.
Collapse
Affiliation(s)
- Paolo Taurisano
- Department of Basic Medical Science, Psychiatric Neuroscience Group, Neuroscience and Sense Organs, University of Bari Aldo Moro Bari, Italy ; IRCCS "Casa Sollievo della Sofferenza", San Giovanni Rotondo Foggia, Italy
| | - Raffaella Romano
- Department of Basic Medical Science, Psychiatric Neuroscience Group, Neuroscience and Sense Organs, University of Bari Aldo Moro Bari, Italy
| | - Marina Mancini
- Department of Basic Medical Science, Psychiatric Neuroscience Group, Neuroscience and Sense Organs, University of Bari Aldo Moro Bari, Italy
| | - Annabella Di Giorgio
- Department of Basic Medical Science, Psychiatric Neuroscience Group, Neuroscience and Sense Organs, University of Bari Aldo Moro Bari, Italy ; IRCCS "Casa Sollievo della Sofferenza", San Giovanni Rotondo Foggia, Italy
| | - Linda A Antonucci
- Department of Basic Medical Science, Psychiatric Neuroscience Group, Neuroscience and Sense Organs, University of Bari Aldo Moro Bari, Italy
| | - Leonardo Fazio
- Department of Basic Medical Science, Psychiatric Neuroscience Group, Neuroscience and Sense Organs, University of Bari Aldo Moro Bari, Italy ; IRCCS "Casa Sollievo della Sofferenza", San Giovanni Rotondo Foggia, Italy
| | - Antonio Rampino
- Department of Basic Medical Science, Psychiatric Neuroscience Group, Neuroscience and Sense Organs, University of Bari Aldo Moro Bari, Italy
| | - Tiziana Quarto
- Department of Basic Medical Science, Psychiatric Neuroscience Group, Neuroscience and Sense Organs, University of Bari Aldo Moro Bari, Italy ; Department of Behavioural Sciences, Cognitive Brain Research Unit, University of Helsinki Helsinki, Finland
| | - Barbara Gelao
- Department of Basic Medical Science, Psychiatric Neuroscience Group, Neuroscience and Sense Organs, University of Bari Aldo Moro Bari, Italy
| | - Annamaria Porcelli
- Department of Basic Medical Science, Psychiatric Neuroscience Group, Neuroscience and Sense Organs, University of Bari Aldo Moro Bari, Italy
| | - Apostolos Papazacharias
- Department of Basic Medical Science, Psychiatric Neuroscience Group, Neuroscience and Sense Organs, University of Bari Aldo Moro Bari, Italy
| | - Gianluca Ursini
- Department of Basic Medical Science, Psychiatric Neuroscience Group, Neuroscience and Sense Organs, University of Bari Aldo Moro Bari, Italy ; Lieber Institute for Brain Development, Johns Hopkins University Medical Campus Baltimore, MD, USA
| | - Grazia Caforio
- Department of Basic Medical Science, Psychiatric Neuroscience Group, Neuroscience and Sense Organs, University of Bari Aldo Moro Bari, Italy
| | - Rita Masellis
- Department of Basic Medical Science, Psychiatric Neuroscience Group, Neuroscience and Sense Organs, University of Bari Aldo Moro Bari, Italy
| | - Artor Niccoli-Asabella
- Department of Internal Medicine and of Public Medicine, Nuclear Medicine Unit, University of Bari Aldo Moro Bari, Italy
| | - Orlando Todarello
- Department of Basic Medical Science, Psychiatric Neuroscience Group, Neuroscience and Sense Organs, University of Bari Aldo Moro Bari, Italy
| | - Teresa Popolizio
- IRCCS "Casa Sollievo della Sofferenza", San Giovanni Rotondo Foggia, Italy
| | - Giuseppe Rubini
- Department of Internal Medicine and of Public Medicine, Nuclear Medicine Unit, University of Bari Aldo Moro Bari, Italy
| | - Giuseppe Blasi
- Department of Basic Medical Science, Psychiatric Neuroscience Group, Neuroscience and Sense Organs, University of Bari Aldo Moro Bari, Italy
| | - Alessandro Bertolino
- Department of Basic Medical Science, Psychiatric Neuroscience Group, Neuroscience and Sense Organs, University of Bari Aldo Moro Bari, Italy ; IRCCS "Casa Sollievo della Sofferenza", San Giovanni Rotondo Foggia, Italy ; pRED, NORD DTA, Hoffmann-La Roche, Ltd. Basel, Switzerland
| |
Collapse
|